Total raised
—
Last: Seed 2025-10
Stage
Seed
Founded
2022
Headcount
9
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
Baccine is a pre-clinical biotechnology company bringing innovative proprietary bacteria-based cancer vaccines to provide new hope for cancer patients. The company’s innovative multi-acting approach aims to provide efficient immunotherapy treatments with increased response rates and reduced side effects via localized action. Baccine was established together with the Weizmann Institute of Science, following years of research focusing on cancer resistance mechanisms, the tumor microenvironment, and the role of bacteria in tumors.
Funding history · 2 rounds · — total
2025-10
Seed
Undisclosed
2024-03
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Baccine founded?
- Baccine was founded in February 2022.
- What is Baccine's primary focus?
- Baccine is a pre-clinical biotechnology company developing proprietary bacteria-based cancer vaccines for immunotherapy treatments.
- What is the current employee count for Baccine?
- Baccine currently has 9 employees.
- Which institute was Baccine established in conjunction with?
- Baccine was established together with the Weizmann Institute of Science.
- When did Baccine receive its undisclosed funding round?
- In March 2024, Baccine received an undisclosed funding round with Marius Nacht as an investor.
- When did Baccine complete its Seed funding round?
- In October 2025, Baccine completed a Seed funding round led by Terra Venture Partners.
- What is Baccine's current funding stage?
- Baccine is currently in the Seed funding stage.
- Where is Baccine's headquarters located?
- Baccine's headquarters is located in Rehovot, Israel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticalsBiotechnology
Business model
B2C
Highlights
Verified
Tags
cancer-therapycancercancer-research